CD86 and rheumatoid arthritis: EVs isolated from plasma of RA patients suppress early B cell activation in RA by downregulating the expression of activation markers like CD69+ and CD86+, and by inhibiting intracellular signaling pathways that are essential for B cell proliferation, function, and survival results (68).